NCT02291263View on ClinicalTrials.gov

Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

738

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

bOPV/IPV (6 weeks)

bOPV at 6, 10 and 14 weeks of age IPV at 6 weeks of age

BIOLOGICAL

bOPV/IPV (14 weeks)

bOPV at 6, 10 and 14 weeks of age IPV at 14 weeks of age

BIOLOGICAL

bOPV/IPV (6 & 14 weeks)

bOPV at 6, 10 and 14 weeks of age IPV at 6 and14 weeks of age

Trial Locations (1)

Unknown

Mirpur clinic (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT02291263 - Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine | Biotech Hunter | Biotech Hunter